UPS (Added by Master RSI on Tue 29 May 11:45 am)
AZM - Mid 94.75p
Reason - Trying to go higher since last Friday after a large retracement and Indicators now gone to well oversold, the latest update is Phase III clinical trial with cetilistat, New patent granted in relation to manufacture of renzapride